Long COVID Impacts Mouth, Lung Bacteria

Introduction to Long COVID

Long COVID, also known as post-acute COVID-19, refers to the persistence of symptoms after recovery from an acute COVID-19 infection. Researchers have been studying the effects of long COVID on the human body, and a recent study has shed light on the impact of long COVID on the bacteria in the mouth and lungs.

The study, published in the European Respiratory Journal, examined 771 people treated for COVID-19 at one of 38 UK hospitals between February 2020 and March 2021. The participants were divided into four groups based on the severity of their symptoms five months after being discharged from hospital.

Background and Context

Long COVID has been a growing concern worldwide, with millions of people still experiencing symptoms months after their initial infection. The condition can affect multiple organs, including the lungs, brain, and gut, and can have a significant impact on a person's quality of life.

Previous studies have shown that changes in the gut microbiome may be associated with long COVID, but the current study is one of the first to investigate the impact of long COVID on the lung microbiome.

Methodology and Findings

Six months after hospital discharge, samples were collected from patients' mouths through saliva and from their lungs through sputum. DNA sequencing was used to identify the microbes present. By analyzing the variety and quantities of microbes and comparing them with patients' symptoms, researchers found that people with very severe long COVID had marked differences in their oral and lung microbiomes compared with those who did not have severe long COVID.

The results also revealed differences linked to specific symptoms, including reduced lung function, in which the lungs cannot hold as much air as normal or air cannot flow in and out as easily. The researchers also found differences in the mouth and lungs microbiome between people with varying neurocognitive symptoms -- including 'brain fog', difficulties with memory, attention and concentration -- and gut symptoms, including pain, nausea, diarrhoea and loss of appetite.

Key Findings

• People with very severe long COVID had distinct differences in their oral and lung microbiomes compared with those who did not have severe long COVID.
• Changes in the airway microbiome were linked not just to lung problems, but also to symptoms like brain fog and gut symptoms.
• An over-abundance of bacteria that produce lactic acid was associated with long-COVID symptoms and signs of inflammation found in samples of patients' blood.

Implications and Future Research

The findings of this study may contribute towards understanding why some people develop long COVID and point to new ways to treat the condition. According to lead author Daniela Alferes de Lima Headley, 'Prior studies have shown some changes in the gut microbiome with long COVID, but Covid is a lung disease and so it makes sense to look to see if the lung microbiome is changed in long COVID.'

Lead researcher James Chalmers, chair of respiratory research at the University of Dundee, UK, said, 'People who had the worst symptoms five to six months after COVID infection had big changes in the microbiome in their mouth and lungs.' He also noted that 'changes in the airway microbiome were linked not just to lung problems, but also to symptoms like brain fog and gut symptoms, suggesting the lung microbiome could have effects on health more broadly.'

Expert Perspective

Experts in the field of respiratory medicine and microbiology have welcomed the study's findings, highlighting the importance of further research into the role of the lung microbiome in long COVID.

'The study's results suggest that the lung microbiome may play a key role in the development and severity of long COVID symptoms,' said Dr. Sanjay Sethi, a pulmonologist at the Postgraduate Institute of Medical Education and Research in Chandigarh, India. 'Further research is needed to explore the potential therapeutic targets for treating long COVID and to understand the mechanisms by which the lung microbiome affects overall health.'

Read also: AI MedTech Regulation in India

Implications for Readers in India

The study's findings have significant implications for readers in India, where long COVID has been a growing concern. The Indian government has launched several initiatives to tackle the condition, including the establishment of long COVID clinics and research centers.

Readers in India can take several steps to reduce their risk of developing long COVID, including getting vaccinated against COVID-19, practicing good hygiene and social distancing, and seeking medical attention if they experience any symptoms of long COVID.

What to Watch Next

As research into long COVID continues to evolve, there are several key areas to watch in the coming months and years. These include the development of new treatments and therapies for long COVID, as well as further research into the role of the lung microbiome in the condition.

Readers can stay up-to-date with the latest developments in long COVID research by following reputable sources of information, such as the World Health Organization and the Indian Council of Medical Research.

Conclusion

In conclusion, the study highlights the importance of the lung microbiome in understanding long COVID and its symptoms. Further research is needed to explore the potential therapeutic targets for treating long COVID and to understand the mechanisms by which the lung microbiome affects overall health.